SCENAR-THERAPY EFFECTIVENESS IN PREVENTING ... Vegas/Yury...SCENAR-THERAPY EFFECTIVENESS IN...

28
SCENAR-THERAPY EFFECTIVENESS IN PREVENTING MYOPIA AND SLOWING DOWN ITS PROGRESSION DEPARTMENT OF PEDIATRICS №4 DEPARTMENT OF OCULAR DISEASES №2 ROSTOV STATE MEDICAL UNIVERSITY

Transcript of SCENAR-THERAPY EFFECTIVENESS IN PREVENTING ... Vegas/Yury...SCENAR-THERAPY EFFECTIVENESS IN...

Page 1: SCENAR-THERAPY EFFECTIVENESS IN PREVENTING ... Vegas/Yury...SCENAR-THERAPY EFFECTIVENESS IN PREVENTING MYOPIA AND SLOWING DOWN ITS PROGRESSION DEPARTMENT OF PEDIATRICS 4 DEPARTMENT

SCENAR-THERAPY EFFECTIVENESS

IN PREVENTING MYOPIA AND

SLOWING DOWN ITS PROGRESSION

DEPARTMENT OF PEDIATRICS №4

DEPARTMENT OF OCULAR DISEASES №2

ROSTOV STATE MEDICAL UNIVERSITY

Page 2: SCENAR-THERAPY EFFECTIVENESS IN PREVENTING ... Vegas/Yury...SCENAR-THERAPY EFFECTIVENESS IN PREVENTING MYOPIA AND SLOWING DOWN ITS PROGRESSION DEPARTMENT OF PEDIATRICS 4 DEPARTMENT

Refraction abnormalities are the main cause of eye disorders in schoolchildren today. The prevalence of myopia among school-aged children is 12 – 35%. Degenerative myopia ranks second among the causes of eye-related handicaps in young adults. Its development is provided by the following factors.

Children of myopic parents are frequently myopic.

Genetic predisposition

Causes compensatory lengthening of sclera.

Primary weakness of accommodation

Background

Page 3: SCENAR-THERAPY EFFECTIVENESS IN PREVENTING ... Vegas/Yury...SCENAR-THERAPY EFFECTIVENESS IN PREVENTING MYOPIA AND SLOWING DOWN ITS PROGRESSION DEPARTMENT OF PEDIATRICS 4 DEPARTMENT

Lead to false and subsequently true myopia. This can be promoted by disorders of the autonomic nervous system, which is actively involved in accommodation, since the pupil sphincter and Brucke's fibers are controlled by the parasympathetic part, and the dilator muscle of pupil and Ivanov’s fibers by the sympathetic part.

Unbalanced, strained accommodation and

convergence

General health condition can contribute much to myopia development. Such diseases as rheumatism, arthritis, chronic tonsillitis exacerbation, infectious hepatitis cause a general weakening of conjunctive tissues in the whole body, including the eye sclera. Such sclera extends readily, causing myopia progression.

General health decline

Professional training, involving too long time in front of video monitors too close to the eyes. When the body development is not completed yet, myopia develops easily and its progression becomes persistent.

Unfavorable environment

Page 4: SCENAR-THERAPY EFFECTIVENESS IN PREVENTING ... Vegas/Yury...SCENAR-THERAPY EFFECTIVENESS IN PREVENTING MYOPIA AND SLOWING DOWN ITS PROGRESSION DEPARTMENT OF PEDIATRICS 4 DEPARTMENT
Page 5: SCENAR-THERAPY EFFECTIVENESS IN PREVENTING ... Vegas/Yury...SCENAR-THERAPY EFFECTIVENESS IN PREVENTING MYOPIA AND SLOWING DOWN ITS PROGRESSION DEPARTMENT OF PEDIATRICS 4 DEPARTMENT

Improvement in microcirculation makes a morphofunctional basis for antihypoxic and anti-edema action, stimulation of metabolic and redox processes as well as reflex-relaxing effect of the method.

Electric pulse stimulation with SCENAR was delivered once daily for 10 days.

Stimulation was applied on peripheral zones that have biologically active points of the Chinese meridians associated with the functional state of the accommodative apparatus of the eye and retina electrogenesis.

SCENAR-therapy was given at the Eye Health Care Office and Eye Department of the District Children’s Hospital.

Page 6: SCENAR-THERAPY EFFECTIVENESS IN PREVENTING ... Vegas/Yury...SCENAR-THERAPY EFFECTIVENESS IN PREVENTING MYOPIA AND SLOWING DOWN ITS PROGRESSION DEPARTMENT OF PEDIATRICS 4 DEPARTMENT

Collar Zone

Page 7: SCENAR-THERAPY EFFECTIVENESS IN PREVENTING ... Vegas/Yury...SCENAR-THERAPY EFFECTIVENESS IN PREVENTING MYOPIA AND SLOWING DOWN ITS PROGRESSION DEPARTMENT OF PEDIATRICS 4 DEPARTMENT

Periorbital Zone

Midpoint of each eyebrow (VT6)

0.3 cm inwards from the nasal

edge of the eye (V1)

Internal point of eyebrow (V2)

External edge of an eyebrow, in the recess that corresponds to the lateral edge of the maxillary process of frontal bone (TR23)

0.5 cm outwards from the tail of the eye, corresponds to the outer edge of eye orbit (VB1)

Center of the lower eyelid (Е1) 1 cm downwards from

the lower eyelid, corresponds to the infraorbital foramen

(Е2)

Page 8: SCENAR-THERAPY EFFECTIVENESS IN PREVENTING ... Vegas/Yury...SCENAR-THERAPY EFFECTIVENESS IN PREVENTING MYOPIA AND SLOWING DOWN ITS PROGRESSION DEPARTMENT OF PEDIATRICS 4 DEPARTMENT

In implementation (+) of the action, both local reflex mechanisms and general response of the body to the stimulation are involved.

Local effects of pulse current manifest themselves as activated blood microcirculation and improved tissue trophism not only locally in the zone of influence but also in the eyeball (as it is the organ corresponding with this skin area) on the principle of dermatovisceral reflex.

Tonographic data proved normalization and/or prevention of microcirculatory-circulatory hypoxia in nearsighted children.

Page 9: SCENAR-THERAPY EFFECTIVENESS IN PREVENTING ... Vegas/Yury...SCENAR-THERAPY EFFECTIVENESS IN PREVENTING MYOPIA AND SLOWING DOWN ITS PROGRESSION DEPARTMENT OF PEDIATRICS 4 DEPARTMENT

Identification of a concomitant somatic pathology

Methods

Identification of burdened family background

Visometry

Refractometry

Accommodation indices (accommodation reserve)

Ophthalmoscopy (examination of the back part

(fundus) of the eye) Neurophysiological measurements

(electrophysiological study)

Echobiometry (measuring the shape of the eyeball)

Page 10: SCENAR-THERAPY EFFECTIVENESS IN PREVENTING ... Vegas/Yury...SCENAR-THERAPY EFFECTIVENESS IN PREVENTING MYOPIA AND SLOWING DOWN ITS PROGRESSION DEPARTMENT OF PEDIATRICS 4 DEPARTMENT

65 children aged 7 to 15

Clinical forms of eye pathology in the groups under test

Clinical Profile of Patients

24.6%

15.4%

32.3%

13.8% 13.8%

Myopic astigmatism

Severe myopia

Spasm of accommodation (pseudomyopia)

Mild and moderate myopia

Eyestrain syndrome

Treatment was given at the Eye Health Care Office and Eye Department of the District Children’s Hospital.

Page 11: SCENAR-THERAPY EFFECTIVENESS IN PREVENTING ... Vegas/Yury...SCENAR-THERAPY EFFECTIVENESS IN PREVENTING MYOPIA AND SLOWING DOWN ITS PROGRESSION DEPARTMENT OF PEDIATRICS 4 DEPARTMENT
Page 12: SCENAR-THERAPY EFFECTIVENESS IN PREVENTING ... Vegas/Yury...SCENAR-THERAPY EFFECTIVENESS IN PREVENTING MYOPIA AND SLOWING DOWN ITS PROGRESSION DEPARTMENT OF PEDIATRICS 4 DEPARTMENT
Page 13: SCENAR-THERAPY EFFECTIVENESS IN PREVENTING ... Vegas/Yury...SCENAR-THERAPY EFFECTIVENESS IN PREVENTING MYOPIA AND SLOWING DOWN ITS PROGRESSION DEPARTMENT OF PEDIATRICS 4 DEPARTMENT
Page 14: SCENAR-THERAPY EFFECTIVENESS IN PREVENTING ... Vegas/Yury...SCENAR-THERAPY EFFECTIVENESS IN PREVENTING MYOPIA AND SLOWING DOWN ITS PROGRESSION DEPARTMENT OF PEDIATRICS 4 DEPARTMENT

4

96

10

70

20

8

70

22

0%

20%

40%

60%

80%

100%

Changes in visual acuity without corrective lenses

5

95

7

30

63

510

85

0%

20%

40%

60%

80%

100%

Before

After

Group I - conventional management

Group II – monotherapy with

SCENAR

Group III – multiple treatment +

SCENAR-therapy

Low visual acuity (<0.1-0.3) Comfortable visual acuity (0.4-0.6) High visual acuity(0.7 and higher)

12 months later

7

93

5

35

60

3

27

70

0%

20%

40%

60%

80%

100%

Before

After

12 months later

Before

After

12 months later

Page 15: SCENAR-THERAPY EFFECTIVENESS IN PREVENTING ... Vegas/Yury...SCENAR-THERAPY EFFECTIVENESS IN PREVENTING MYOPIA AND SLOWING DOWN ITS PROGRESSION DEPARTMENT OF PEDIATRICS 4 DEPARTMENT

> 70 µA 70 µA (normal)

Changes of Neurophysiological Indices

Retinal Electrosensitivity

10

90

50

50

5

95

12

88

70

30

50

50

9

91100 100

0%

20%

40%

60%

80%

100%

Group I Group II Group III

12

months

later

12

months

later

before before

before after after after

12

months

later

Page 16: SCENAR-THERAPY EFFECTIVENESS IN PREVENTING ... Vegas/Yury...SCENAR-THERAPY EFFECTIVENESS IN PREVENTING MYOPIA AND SLOWING DOWN ITS PROGRESSION DEPARTMENT OF PEDIATRICS 4 DEPARTMENT

Changes of Neurophysiological Indices

50

50

55

45

50

50

40

60

70

30

60

40

45

55

100 100

0%

20%

40%

60%

80%

100%

12

months

later

after

Optic Nerve Electroliability

< 45 Hz 45 Hz (normal)

12

months

later

before

before before

after after 12

months

later

Group I Group II Group III

Page 17: SCENAR-THERAPY EFFECTIVENESS IN PREVENTING ... Vegas/Yury...SCENAR-THERAPY EFFECTIVENESS IN PREVENTING MYOPIA AND SLOWING DOWN ITS PROGRESSION DEPARTMENT OF PEDIATRICS 4 DEPARTMENT
Page 18: SCENAR-THERAPY EFFECTIVENESS IN PREVENTING ... Vegas/Yury...SCENAR-THERAPY EFFECTIVENESS IN PREVENTING MYOPIA AND SLOWING DOWN ITS PROGRESSION DEPARTMENT OF PEDIATRICS 4 DEPARTMENT
Page 19: SCENAR-THERAPY EFFECTIVENESS IN PREVENTING ... Vegas/Yury...SCENAR-THERAPY EFFECTIVENESS IN PREVENTING MYOPIA AND SLOWING DOWN ITS PROGRESSION DEPARTMENT OF PEDIATRICS 4 DEPARTMENT
Page 20: SCENAR-THERAPY EFFECTIVENESS IN PREVENTING ... Vegas/Yury...SCENAR-THERAPY EFFECTIVENESS IN PREVENTING MYOPIA AND SLOWING DOWN ITS PROGRESSION DEPARTMENT OF PEDIATRICS 4 DEPARTMENT
Page 21: SCENAR-THERAPY EFFECTIVENESS IN PREVENTING ... Vegas/Yury...SCENAR-THERAPY EFFECTIVENESS IN PREVENTING MYOPIA AND SLOWING DOWN ITS PROGRESSION DEPARTMENT OF PEDIATRICS 4 DEPARTMENT
Page 22: SCENAR-THERAPY EFFECTIVENESS IN PREVENTING ... Vegas/Yury...SCENAR-THERAPY EFFECTIVENESS IN PREVENTING MYOPIA AND SLOWING DOWN ITS PROGRESSION DEPARTMENT OF PEDIATRICS 4 DEPARTMENT
Page 23: SCENAR-THERAPY EFFECTIVENESS IN PREVENTING ... Vegas/Yury...SCENAR-THERAPY EFFECTIVENESS IN PREVENTING MYOPIA AND SLOWING DOWN ITS PROGRESSION DEPARTMENT OF PEDIATRICS 4 DEPARTMENT
Page 24: SCENAR-THERAPY EFFECTIVENESS IN PREVENTING ... Vegas/Yury...SCENAR-THERAPY EFFECTIVENESS IN PREVENTING MYOPIA AND SLOWING DOWN ITS PROGRESSION DEPARTMENT OF PEDIATRICS 4 DEPARTMENT

CHANGE OF ACCOMMODATION RESERVE

Group I Group II Group

III

Accommodation Reserve: no reserve (0 – 0.25 dioptres) low reserve (up to 1.5 dioptres) normal reserve (3.0 dioptres and higher)

Group I Group II Group

III

Before treatment

12 months later

20%

70% 10%

75%

25%

5% 80%

15%

65%

35%

0,5%

34,5%

65%

70%

30%

After treatment

Group I Group II Group

III

5%

50%

45% 10%

15% 75%

60%

39,5% 0,5%

Page 25: SCENAR-THERAPY EFFECTIVENESS IN PREVENTING ... Vegas/Yury...SCENAR-THERAPY EFFECTIVENESS IN PREVENTING MYOPIA AND SLOWING DOWN ITS PROGRESSION DEPARTMENT OF PEDIATRICS 4 DEPARTMENT

Myopia progression after 12 months

5%

70%

95%

75%

30% 25%

0

10

20

30

40

50

60

70

80

90

100

stabilization progression

Group I

Group II

Group III

Page 26: SCENAR-THERAPY EFFECTIVENESS IN PREVENTING ... Vegas/Yury...SCENAR-THERAPY EFFECTIVENESS IN PREVENTING MYOPIA AND SLOWING DOWN ITS PROGRESSION DEPARTMENT OF PEDIATRICS 4 DEPARTMENT

Long-term effects of SCENAR-therapy (12 months

later)

Beneficial action of SCENAR in nearsighted children:

- In 78% children their vision acuity remained in the

visual comfort limits

- Neurophysiological indices became normal

in 100% cases

- Functional state of the accommodative

apparatus became normal in 60%

Page 27: SCENAR-THERAPY EFFECTIVENESS IN PREVENTING ... Vegas/Yury...SCENAR-THERAPY EFFECTIVENESS IN PREVENTING MYOPIA AND SLOWING DOWN ITS PROGRESSION DEPARTMENT OF PEDIATRICS 4 DEPARTMENT

CONCLUSION

Including SCENAR-therapy in the

conventional management prevents

myopia in 80% cases and stops

myopia progression in 70%.

Page 28: SCENAR-THERAPY EFFECTIVENESS IN PREVENTING ... Vegas/Yury...SCENAR-THERAPY EFFECTIVENESS IN PREVENTING MYOPIA AND SLOWING DOWN ITS PROGRESSION DEPARTMENT OF PEDIATRICS 4 DEPARTMENT

Thank you!